Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Kairos Pharma (KAPA) Profit After Tax (2024 - 2025)

Historic Profit After Tax for Kairos Pharma (KAPA) over the last 2 years, with Q2 2025 value amounting to -$1.4 million.

  • Kairos Pharma's Profit After Tax fell 46205.53% to -$1.4 million in Q2 2025 from the same period last year, while for Jun 2025 it was -$4.7 million, marking a year-over-year change of. This contributed to the annual value of -$2.6 million for FY2024, which is 4365.34% down from last year.
  • Per Kairos Pharma's latest filing, its Profit After Tax stood at -$1.4 million for Q2 2025, which was down 46205.53% from -$1.3 million recorded in Q1 2025.
  • In the past 5 years, Kairos Pharma's Profit After Tax registered a high of -$253000.0 during Q2 2024, and its lowest value of -$1.4 million during Q2 2025.